Indications
Treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)
Composition
- Active substance
- Maralixibat chloride
- International name (INN)
- maralixibat
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Livmarli
- Active substance
- Maralixibat chloride
- ATC code
- A05AX
- Therapeutic area
- Cholestasis, Intrahepatic
- Marketing authorisation holder
- FGK Representative Service GmbH
- Status
- Application withdrawn